Vimedimex Medi-Pharma JSC (HOSE:VMD)
Vietnam · Delayed Price · Currency is VND 15,600
+200 (1.30%)
At close: Feb 9, 2026
Vimedimex Medi-Pharma JSC Revenue
Vimedimex Medi-Pharma JSC had revenue of 268.38B VND in the quarter ending June 30, 2025, a decrease of -12.47%. This brings the company's revenue in the last twelve months to 1.17T, down -57.31% year-over-year. In the year 2024, Vimedimex Medi-Pharma JSC had annual revenue of 1.25T, down -64.67%.
Revenue (ttm)
1.17T
Revenue Growth
-57.31%
P/S Ratio
0.21
Revenue / Employee
37.84B
Employees
31
Market Cap
240.87B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 1.25T | -2,287.15B | -64.67% |
| Dec 31, 2023 | 3.54T | -3,536.85B | -50.00% |
| Jan 1, 2023 | 7.07T | -5,245.25B | -42.58% |
| Dec 31, 2021 | 12.32T | -5,843.44B | -32.17% |
| Dec 31, 2020 | 18.16T | -76.79B | -0.42% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jan 1, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Domesco Medical Import - Export Joint-Stock | 2.08T |
| OPC Pharmaceutical JSC | 1.06T |
| Vidipha Central Pharmaceutical JSC | 950.89B |
| Ben Tre Pharmaceutical JSC | 860.40B |
| Pharmedic Pharmaceutical Medicinal JSC | 546.57B |
| Central Pharmaceutical Joint Stock Company No3 | 438.01B |
| Mediplantex National Pharmaceutical JSC | 367.08B |
| SPM Corporation | 253.96B |